How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease

• Ngā kaituhi matua: Maria Galvez-Llompart (Author), Riccardo Zanni (Author), Ramon Garcia-Domenech (Author), Jorge Galvez (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Even if amyotrophic lateral sclerosis is still considered an orphan disease to date, its prevalence among the population is growing fast. Despite the efforts made by researchers and pharmaceutical companies, the cryptic information related to the biological and physiological onset mechanisms, as wel...